Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

Clinical trial NCT00004196 · COMPLETED

Trial details

NCT number: NCT00004196
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1999-10-01
Primary completion: 2004-10-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.